Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1898255

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1898255

Blood Glucose Monitoring Devices Market Size, Share, and Growth Analysis, By Product (Blood Glucose Monitors, Glucose Monitoring Strips), By Application (Hospitals and Clinics, Diagnostic Centers), By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 242 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Blood Glucose Monitoring Devices Market size was valued at USD 14.66 Billion in 2024 and is poised to grow from USD 15.88 Billion in 2025 to USD 30.05 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The global market for blood glucose monitoring devices is experiencing significant growth, driven by the escalating incidence of diabetes and the rising demand for precise and dependable monitoring solutions. Technological advancements in devices, including insulin pens and continuous glucose monitoring systems, have improved patient outcomes and device functionality. Notably, the healthcare sector provides accessibility to these essential tools, as glucose monitoring devices are covered under various health insurance plans, facilitating patient management of diabetes. Increased awareness of the critical need for glycemic control and the risks associated with unmanaged diabetes is further propelling device adoption. Consequently, blood glucose meters are becoming vital for individuals to monitor their blood sugar levels effectively, ensuring timely adjustments in their treatment regimens.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blood Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blood Glucose Monitoring Devices Market Segments Analysis

Global Blood Glucose Monitoring Devices Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Blood Glucose Monitors, Glucose Monitoring Strips, and Lancets. Based on Application, the market is segmented into Hospitals and Clinics, Diagnostic Centers, and Home Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Blood Glucose Monitoring Devices Market

The increasing prevalence of diabetes globally serves as a key catalyst for the expansion of the blood glucose monitoring devices market. Factors contributing to this rise include an aging population, along with shifts in lifestyle and eating habits, which have led to higher incidences of both type 1 and type 2 diabetes. This upsurge underscores the urgent need for effective glucose monitoring solutions to manage blood sugar levels, thereby preventing potential complications associated with the condition. As more individuals seek to maintain their health through regular monitoring, the demand for advanced blood glucose monitoring devices continues to grow significantly.

Restraints in the Blood Glucose Monitoring Devices Market

The high cost of advanced blood glucose monitoring devices, particularly continuous glucose monitoring systems, poses a significant barrier to accessibility for many patients. In areas lacking healthcare subsidies or reimbursement options, the financial burden associated with these technologies restricts their adoption, particularly among low-income populations. This limited accessibility results in a reduced market segment, ultimately stunting the overall growth of the blood glucose monitoring devices market. The disparity in affordability further emphasizes the need for more inclusive pricing strategies and support initiatives to enhance patient access and drive wider acceptance of these essential monitoring tools.

Market Trends of the Blood Glucose Monitoring Devices Market

The Blood Glucose Monitoring Devices market is increasingly witnessing a shift towards Continuous Glucose Monitoring (CGM) systems, which offer real-time glucose readings and significantly improve diabetes management. These advanced devices enhance accuracy, usability, and user-friendly designs, making them more appealing to both individuals and healthcare providers. As patients seek more efficient ways to monitor their glucose levels, the adoption of CGM systems is proliferating in both home settings and clinical institutions. This trend is indicative of a broader movement towards personalized healthcare solutions, where technology plays a critical role in empowering patients to take control of their health.

Product Code: SQMIG35A2338

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Trade Analysis
  • Supply chain Analysis
  • Case study Analysis
  • Patent Analysis
  • Customer & Buying Criteria Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Blood Glucose Monitoring Devices Market by Product

  • Market Overview
  • Blood Glucose Monitors
    • Single Point Blood Glucose Meters
    • Continuous Glucose Monitoring Systems
    • Sensors
    • Transmitter and Receivers
    • External Monitor
  • Glucose Monitoring Strips
  • Lancets

Blood Glucose Monitoring Devices Market by Application

  • Market Overview
  • Hospitals and Clinics
  • Diagnostic Centers
  • Home Settings

Blood Glucose Monitoring Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • Abbott (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novo Nordisk (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insulet Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed Holdings (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glysens Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARKRAY, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AgaMatrix, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trividia Health, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MediWise Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaMonTech AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sinocare, Inc. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Menarini Diagnostics (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beurer GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prodigy Diabetes Care, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omron Healthcare, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!